Physician profile
Peter B Sherer
NPI 1316950066
$9,721.03
in general payments reported to CMS, 2019-2025
18 companies · $3,133 in 2025
The $3,133 reported for 2025 was more than what 96% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $150 · 2020: $110 · 2021: $520 · 2022: $3,053 · 2024: $2,755 · 2025: $3,133.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $2,498 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,000 · Travel and Lodging: $1,045 · Food and Beverage: $345.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $2,497.50 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,000.00 |
| Travel and Lodging | $1,045.21 |
| Food and Beverage | $345.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $5,857.47 | 2019-2024 | Imfinzi |
| Avyxa Pharma, LLC | $3,132.60 | 2025 | |
| Janssen Biotech, INC. | $183.60 | 2021 | |
| Pfizer INC. | $156.64 | 2019-2021 | |
| Abbvie INC. | $91.74 | 2021 | |
| Esperion Therapeutics, INC. | $48.44 | 2021 | |
| Novo Nordisk INC | $37.39 | 2019-2021 | |
| Clovis Oncology, INC. | $37.20 | 2020-2021 | |
| Eisai INC. | $31.31 | 2021 | |
| Allergan, INC. | $28.30 | 2020 | |
| Sunovion Pharmaceuticals INC. | $22.49 | 2021 | |
| Seagen INC. | $18.03 | 2021 | |
| Astellas Pharma US INC | $17.07 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $13.07 | 2020 | |
| Almatica Pharma LLC | $11.88 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alexion Pharmaceuticals, INC. | $11.69 | 2019 | |
| Sanofi Pasteur INC. | $11.31 | 2019 | |
| Merck Sharp & Dohme LLC | $10.80 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Sherer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.